These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 302996)

  • 1. Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.
    Hilgartner MW; Giardina P
    Transfusion; 1977; 17(5):495-9. PubMed ID: 302996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liver dysfunction in multitransfused hemophiliacs.
    Hasiba UW; Spero JA; Lewis JH
    Transfusion; 1977; 17(5):490-4. PubMed ID: 910267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders.
    Ng HW
    Ann Acad Med Singap; 1984 Jul; 13(3):524-6. PubMed ID: 6335008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transaminase levels in patients with hemophilia or von Willebrand's disease].
    Celada A; Ortega F; Magallón M; Martín-Villar J
    Sangre (Barc); 1984; 29(6):965-72. PubMed ID: 6335927
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
    Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in haemophilia and von Willebrand's disease.
    Passaleva A; Massai G; Morfini M; Longo G; Rossi Ferrini PL; Ricci M
    Scand J Haematol; 1983 Nov; 31(5):466-74. PubMed ID: 6606214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in hemophilia.
    Poskitt TR; Poskitt PK; Bean CA; Arkel YS
    Am J Hematol; 1981 Sep; 11(2):147-52. PubMed ID: 6795922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of serological and biological markers in viral hepatitis. 157 hemophiliacs].
    Parquet-Gernez A; Boulanger-Fasquelle P; Maniez-Montreuil M; Goudemand M
    Rev Fr Transfus Immunohematol; 1981 Nov; 24(5):463-82. PubMed ID: 6798669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
    Enck RE; Betts RF; Brown MR; Miller G
    Transfusion; 1979; 19(1):32-8. PubMed ID: 219564
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.
    Federici AB; Santagostino E; Rumi MG; Russo A; Mancuso ME; Soffredini R; Mannucci PM; Colombo M
    Haematologica; 2006 Apr; 91(4):503-8. PubMed ID: 16585016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C antibody and chronic liver disease in haemophilia.
    Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M
    Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders.
    Anh-Tuan N; Novák E; Hollán SR
    Vox Sang; 1981 Jan; 40(1):12-6. PubMed ID: 6971526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.
    Card RT; Dusevic M; Lukie BE
    Can Med Assoc J; 1982 Jan; 126(1):34-6. PubMed ID: 7059871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area.
    Ruggiero G; Cesaro G; Mazzella C; Gaeta GB; Miraglia E; Mastrullo L; Boffa ML; Spiteri D; Schiattarella V; de Biasi R
    Hepatogastroenterology; 1985 Apr; 32(2):57-60. PubMed ID: 4007763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against Australia-antigen in haemophilia.
    Nordenfelt E; Nilsson IM
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan.
    Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R
    Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.
    Blombäck M; Kjellman H; Schulman S; Egberg N; Böttiger B; Wiechel B
    Infection; 1987; 15(4):248-52. PubMed ID: 3499399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SGPT increase in hemophilia patients during treatment with blood coagulation factor preparations].
    Kunst VA; Geerdink P
    Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1513-9. PubMed ID: 492366
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.